ZMIZ1 and glioblastoma: We identified five lncRNA biomarkers associated with prognosis of GBM patients, LINC00152, LINC01574, ZMIZ1-AS1, LOXL1-AS1 and TMEM220-AS1, all of which were highly expressed in GBM and correlated with lower OS (p = 0).